| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$416 |
Change in substantial holding from MUFG
|
29 Aug 2025 2:47PM |
$2.825 |
$2.230 |
fallen by
21.06%
|
|
| Axtec Limited (AXI) ORDINARY FULLY PAID |
Real Estate |
$7 |
Appendix 4G Key to Disclosures
|
29 Aug 2025 2:46PM |
$0.021 |
$0.013 |
fallen by
38.10%
|
|
| Heavy Rare Earths Limited (HRE) ORDINARY FULLY PAID |
Materials |
$7 |
Change of Director's Interest Notice X2
|
29 Aug 2025 2:46PM |
$0.049 |
$0.033 |
fallen by
32.65%
|
|
| Patrys Limited (PAB) ORDINARY FULLY PAID |
Health Care |
$26 |
Appendix 4E - Preliminary Final Report
|
29 Aug 2025 2:46PM |
$0.002 |
$0.039 |
risen by
2,500%
|
|
PAB - Price-sensitive ASX Announcement
Full Release
Key Points
- Patrys Limited reported a net loss of $3,013,303 for the financial year ending June 30, 2025, down 14.9% from the previous year.
- The company's cash balance as of June 30, 2025, was $742,441, showing a significant decrease from $2,240,661 the previous year.
- Patrys Limited did not pay, recommend, or declare any dividends during the current or previous financial year.
- The company's research and development expenditure for the year was $1,754,163.
- Net tangible assets per ordinary security were reported at 0.03 cents, down from 0.15 cents the previous year.
- The financial statements are unaudited but are in the process of being audited by BDO Audit Pty Ltd.
- An emphasis of matter regarding material uncertainty in relation to going concern is expected upon audit completion.
- Patrys Limited focuses on the development of novel anti-DNA antibodies for cancer treatment.
- The appendix details significant movements in issued capital and reserves, including share issuances and reallocation of expired and cancelled options.
- The company terminated a licensing agreement with Payload Therapeutics for anti-cancer agents development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Patrys Limited (PAB) ORDINARY FULLY PAID |
Health Care |
$26 |
Appendix 4E - Preliminary Final Report
|
29 Aug 2025 2:46PM |
$0.002 |
$0.039 |
risen by
2,500%
|
|
PAB - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after income tax of $3,013,303, down 14.9% from prior year
- Total other income decreased to $828,540 due to lower R&D tax incentives
- No dividends declared for the current or previous financial year
- Research and development expenditure was $1,754,163
- Cash balance at 30 June 2025 was $742,441
- Net asset position of $732,874
- Share issues and reallocation of expired options conducted
- Auditor expected to note material uncertainty on going concern
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flagship Investments Limited (FSI) ORDINARY FULLY PAID |
Financials |
$31 |
FSI Appendix 4G 2025
|
29 Aug 2025 2:45PM |
$2.150 |
$1.190 |
fallen by
44.65%
|
|
| Flagship Investments Limited (FSI) ORDINARY FULLY PAID |
Financials |
$31 |
Corporate Governance Statement 2025
|
29 Aug 2025 2:45PM |
$2.150 |
$1.190 |
fallen by
44.65%
|
|
| Flagship Investments Limited (FSI) ORDINARY FULLY PAID |
Financials |
$31 |
FSI Annual Report to shareholders
|
29 Aug 2025 2:45PM |
$2.150 |
$1.190 |
fallen by
44.65%
|
|
| I Synergy Group Limited (IS3) ORDINARY FULLY PAID |
Information Technology |
$18 |
Half Yearly Report and Accounts
|
29 Aug 2025 2:44PM |
$0.009 |
$0.255 |
risen by
2,733.33%
|
|
IS3 - Price-sensitive ASX Announcement
Full Release
Key Points
- Net asset deficit of A$1,094,472
- Total comprehensive loss of A$78,949
- Revenue for the half-year at A$378,627
- Basic and diluted loss per share of 0.01 cents
- Loss before taxation of A$57,703
- Issued capital increased through share issuance
- Current and non-current assets and liabilities outlined
- Equity structure and reserves detailed
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| I Synergy Group Limited (IS3) ORDINARY FULLY PAID |
Information Technology |
$18 |
Half Yearly Report and Accounts
|
29 Aug 2025 2:44PM |
$0.009 |
$0.255 |
risen by
2,733.33%
|
|
IS3 - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss reported for the half-year ended 30 June 2025.
- Revenue decreased compared to the previous year.
- Loss before taxation was A$57,703.
- Negative total equity despite issuing additional shares.
- Increase in administrative expenses.
- Foreign currency translation losses impacted comprehensive income.
- Strategic cost management and resource allocation maintained.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EVZ Limited (EVZ) ORDINARY FULLY PAID |
Industrials |
$74 |
Application for quotation of securities - EVZ
|
29 Aug 2025 2:38PM |
$0.170 |
$0.610 |
risen by
258.82%
|
|
| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
H1 FY2025 Results Presentation
|
29 Aug 2025 2:38PM |
$0.018 |
$0.007 |
fallen by
63.89%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue grew by 12.8% YoY to $7.6 million.
- Gross margin increased to 37% from 35%.
- Adjusted EBITDA loss of $2.2 million recorded.
- Operating expenses rose due to acquisitions and closures.
- Cash flow remained neutral with $1.1 million cash balance.
- Focus on e-commerce and innovative launches in H2 FY2025.
- Targeting profitability with optimized operations and new product launches.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
H1 FY2025 Results Presentation
|
29 Aug 2025 2:38PM |
$0.018 |
$0.007 |
fallen by
63.89%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 12.8% YoY to $7.6 million.
- Gross margin improved to 37%, supported by e-commerce.
- Adjusted EBITDA loss widened to $2.2 million.
- Healthy Chef acquisition drove revenue growth.
- Americas segment revenue decreased, focusing on e-commerce.
- Operating cash flow burn reduced, maintaining neutral cash flow.
- Focus on business simplification and profitability in H2 FY2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lindian Resources Limited (LIN) ORDINARY FULLY PAID |
Materials |
$1,720 |
Cleansing notice
|
29 Aug 2025 2:37PM |
$0.265 |
$0.930 |
risen by
250.94%
|
|
| Heavy Rare Earths Limited (HRE) ORDINARY FULLY PAID |
Materials |
$7 |
Notification of cessation of securities - HRE
|
29 Aug 2025 2:36PM |
$0.049 |
$0.033 |
fallen by
32.65%
|
|
| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
H1 FY2025 Results Announcement
|
29 Aug 2025 2:35PM |
$0.018 |
$0.007 |
fallen by
63.89%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue growth of 12.8% YoY to $7.6M.
- Gross margin increased to 37%.
- Operating expenses rose to $5.7M.
- Adjusted EBITDA loss of $2.2M.
- Improved cash discipline reduced outflows to $1.4M.
- Net assets at $7.0M, focusing on working capital reduction.
- Strategic focus on integration and cost rationalization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
H1 FY2025 Results Announcement
|
29 Aug 2025 2:35PM |
$0.018 |
$0.007 |
fallen by
63.89%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue growth of 12.8% year-over-year to $7.6 million.
- Adjusted EBITDA loss of $2.2 million.
- Gross margin improved to 37%.
- Operating expenses increased due to acquisitions and facility closures.
- Reduced operating cash outflows, demonstrating improved cash discipline.
- Strategic focus on e-commerce and margin gains.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
H1 FY2025 Results - Appendix 4D
|
29 Aug 2025 2:35PM |
$0.018 |
$0.007 |
fallen by
63.89%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Elixinol recorded a 12.8% revenue growth in H1 FY2025.
- Adjusted EBITDA loss widened to $2,220,000.
- Australian operations remained the primary revenue driver.
- US operations saw reduced marketing activities affecting performance.
- Secured a $1,325,000 debt facility for liquidity support.
- Cash balance on 30 June 2025 was $1,087,000.
- No dividends were declared during H1 FY2025.
- Impairment charges amounted to $288,000.
- The company anticipates a strong second half with new product launches.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
H1 FY2025 Results - Appendix 4D
|
29 Aug 2025 2:35PM |
$0.018 |
$0.007 |
fallen by
63.89%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 12.8% to $7,642,000.
- Loss after tax increased by 12.2% to $3,093,000.
- No dividends were paid or declared.
- Net tangible assets per security decreased to -1.12 cents.
- Increased issued shares and accumulated losses.
- Review report notes use of going concern basis for preparation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lindian Resources Limited (LIN) ORDINARY FULLY PAID |
Materials |
$1,720 |
Application for quotation of securities - LIN
|
29 Aug 2025 2:35PM |
$0.265 |
$0.930 |
risen by
250.94%
|
|
| Decidr AI Industries Ltd (DAI) ORDINARY FULLY PAID |
Consumer Staple |
$160 |
Application for quotation of securities - DAI
|
29 Aug 2025 2:34PM |
$0.640 |
$0.455 |
fallen by
28.91%
|
|
| Vinyl Group Ltd (VNL) ORDINARY FULLY PAID |
Information Technology |
$77 |
Appendix 4G and Corporate Governance Statement
|
29 Aug 2025 2:33PM |
$0.092 |
$0.052 |
fallen by
43.48%
|
|
| DTI Group Limited (DTI) ORDINARY FULLY PAID |
Information Technology |
$10 |
Preliminary Final Report
|
29 Aug 2025 2:31PM |
$0.008 |
$0.011 |
risen by
37.50%
|
|
DTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss after tax for the year was $1,691,731.
- Sales revenue increased to $8,577,909.
- Operational overheads and cost of goods sold impacted profitability.
- Adelaide Metro Operations upgrade is a key project.
- DTI is focusing on expanding global partnerships.
- The company aims for sustainable revenue growth in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DTI Group Limited (DTI) ORDINARY FULLY PAID |
Information Technology |
$10 |
Preliminary Final Report
|
29 Aug 2025 2:31PM |
$0.008 |
$0.011 |
risen by
37.50%
|
|
DTI - Price-sensitive ASX Announcement
Full Release
Key Points
- DTI Group Limited reported a net loss of $1,691,731 for the financial year ending 30 June 2025.
- Sales revenue for the year was $8,577,909, with a gross margin of $1,451,003.
- The company witnessed a decrease in operational overheads and an increase in cost of goods sold compared to the previous year.
- Total comprehensive loss attributable to the owners of DTI Group was $1,730,369.
- Basic and diluted earnings per share were both -0.37 cents.
- Cash and cash equivalents decreased to $359,623.
- The company released shares raising $2,691,309 and incurred capital raising costs of $71,308.
- Right of use assets and lease liabilities showed significant changes with current amounts being $105,018 and $109,489 respectively in 2025.
- Intangible assets are valued at $2,142,627 after amortization expenses.
- DTI Group is optimistic about future prospects with ongoing projects and international expansion plans, evidenced by activities and partnerships across Australia, Europe, and North America.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MA Credit Income Trust (MA1) ORDINARY UNITS FULLY PAID |
- |
$559 |
Daily Estimate NTA for 28.08.2025
|
29 Aug 2025 2:31PM |
$2.040 |
$2.000 |
fallen by
1.96%
|
|
Call 1300 880 160
Start a chat
Schedule a call
